Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR IMPROVING LIFE QUALITY OF ELDERLY PEOPLE ON BASIS OF VITAMIN K2, PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/178840
Kind Code:
A1
Abstract:
A pharmaceutical composition for improving the life quality of elderly people on the basis of vitamin K2, the pharmaceutical composition being composed of composition I and composition II, the mass ratio of which is (0.5-7):1. Also provided are a preparation method for the pharmaceutical composition and use thereof. The pharmaceutical composition has the main effects of resisting cancer and resisting senile dementia, and also has the effects of strengthening bones, improving osteoporosis, resisting aging, resisting oxidation, improving memory and cognition, reducing blood fat, protecting the liver, and the like, so that the life quality of elderly people can be effectively improved, and health support and protection are provided. Each component in the pharmaceutical composition is stable in activity and high in bioavailability. The technical defects of the present product for elderly people of single function, poor absorption and utilization effect, large gastrointestinal stimulation, strong side effects, and poor palatability are overcome, and there are not any toxic or side effects after long-term administration.

Inventors:
HE TIANMING (CN)
SHI LUQIU (CN)
XUE HONGYU (CN)
SU GUIZHEN (CN)
Application Number:
PCT/CN2022/097816
Publication Date:
September 28, 2023
Filing Date:
June 09, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
NANJING SHENGDE INST OF BIOTECHNOLOGY CO LTD (CN)
NANJING YI SHENG KANG PIN BIOLOGY SCIENCE AND TECH CO LTD (CN)
International Classes:
A23L33/10; A61K31/7032; A23L33/105; A23L33/115; A23L33/12; A23L33/15; A23L33/17; A23P10/30; A61K9/48; A61K31/122; A61K31/202; A61K31/26; A61K31/7012; A61P1/16; A61P3/06; A61P19/08; A61P19/10; A61P25/00; A61P25/28; A61P35/00; A61P37/02; A61P39/06
Foreign References:
CN101828707A2010-09-15
CN109329455A2019-02-15
CN112089709A2020-12-18
CN112888320A2021-06-01
CN110547455A2019-12-10
CN113813252A2021-12-21
CN112399847A2021-02-23
CN113412862A2021-09-21
Other References:
JIANG YAN, XU JIE, DONG YANG-YANG, ZHAO LI-YAN, ZHANG WAN-MING: "The Neuroprotective Effect of Ginsenoside Compound K on Neurodegenerative Diseases", ACTA NEUROPHARMACOLOGICA, vol. 11, no. 4, 31 August 2021 (2021-08-31), pages 49 - 57, XP093094319, ISSN: 2095-1396, DOI: 10.3969/j.issn.2095-1396.2021.04.009
IOLASCON, G. ET AL.: "ARE DIETARY SUPPLEMENTS AND NUTRACEUTICALS EFFECTIVE FOR MUSCULOSKELETAL HEALTH AND COGNITIVE FUNCTION? A SCOPING REVIEW", THE JOURNAL OF NUTRITION, HEALTH & AGING, vol. 21, no. 5, 31 December 2017 (2017-12-31), pages 527 - 538, XP036220631, DOI: 10.1007/s12603-016-0823-x
Attorney, Agent or Firm:
NANJING ZHONGQING KEZHI INTELLECTUAL PROPERTY AGENCY OFFICE (GENERAL PARTNERSHIP) (CN)
Download PDF: